BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Vries CR, Chen Q, Demirdjian S, Kaber G, Khosravi A, Liu D, Van Belleghem JD, Bollyky PL. Phages in vaccine design and immunity; mechanisms and mysteries. Curr Opin Biotechnol 2021;68:160-5. [PMID: 33316575 DOI: 10.1016/j.copbio.2020.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhu J, Jain S, Sha J, Batra H, Ananthaswamy N, Kilgore PB, Hendrix EK, Hosakote YM, Wu X, Olano JP, Kayode A, Galindo CL, Banga S, Drelich A, Tat V, Tseng CK, Chopra AK, Rao VB. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine. mBio 2022;:e0182222. [PMID: 35900097 DOI: 10.1128/mbio.01822-22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Piekarowicz A, Kłyż A, Stein DC. A New Vaccination Method Based on Phage NgoΦ6 and Its Phagemid Derivatives. Front Microbiol 2022;13:793205. [PMID: 35572628 DOI: 10.3389/fmicb.2022.793205] [Reference Citation Analysis]
3 Zhu J, Jain S, Sha J, Batra H, Ananthaswamy N, Kilgore PB, Hendrix EK, Hosakote YM, Wu X, Olano JP, Kayode A, Galindo CL, Banga S, Drelich A, Tat V, Tseng CK, Chopra AK, Rao VB. A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine.. [DOI: 10.1101/2022.04.28.489809] [Reference Citation Analysis]
4 Meile S, Du J, Dunne M, Kilcher S, Loessner MJ. Engineering therapeutic phages for enhanced antibacterial efficacy. Curr Opin Virol 2021;52:182-91. [PMID: 34952266 DOI: 10.1016/j.coviro.2021.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]